Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001106578-25-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DTI | 2025-12-10 | 2025-12-08 | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | $0.00 | -5,000 | 11.0K | -31% | $0 |
| DMT | 2025-12-10 | 2025-12-09+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-12-10 | 2025-12-09+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $479.17 | -8,000 | 130 | -98% | -$3.83M |
| DMT | 2025-12-10 | 2025-12-09+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -8,000 | 30.0K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | G | D | 5,000 | $0.00 | 10,962 | I By Trust | — | — | (F1) Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| 2 | Common | Common Stock | 2025-12-09 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-09 | S | D | 2,440 | $477.63 | 1,690 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $477.40 to $478.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-12-09 | S | D | 1,560 | $479.33 | 130 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $479.00 to $479.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-12-10 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-10 | S | D | 1,000 | $477.92 | 3,130 | D | — | — | |
| 7 | Common | Common Stock | 2025-12-10 | S | D | 1,600 | $480.17 | 1,530 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $479.62 to $480.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-12-10 | S | D | 400 | $480.71 | 1,130 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $480.64 to $480.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2025-12-10 | S | D | 1,000 | $481.72 | 130 | D | — | — | |
| 10 | Derivative | Stock Option | 2025-12-10 | M | D | 4,000 | $0.00 | 26,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 11 | Derivative | Stock Option | 2025-12-09 | M | D | 4,000 | $0.00 | 30,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock |